Austin Research Site Seeks Norovirus Vaccine Trialists
Tekton Research is enrolling participants aged 60 and older for a Phase 3 clinical study on a new mRNA norovirus vaccine.
Updated on Oct. 21, 2026 in Nursing Jobs
Live Poll
Would you participate in a clinical trial to help test a new vaccine?
Tekton Research in Austin is currently seeking 250 local volunteers to join a global Phase 3 clinical trial for a norovirus vaccine. The study aims to evaluate the efficacy of the mRNA-based vaccine in preventing infection or reducing symptoms among seniors.
Why it matters
Norovirus is a major public health burden in the U.S., resulting in up to 21 million annual cases and 100,000 hospitalizations. Developing an effective vaccine could significantly decrease the severity of the virus, which is particularly dangerous for older populations.
The study targets 250 participants locally, contributing to a global cohort of over 37,000 volunteers. Nationally, norovirus causes 900 deaths and 100,000 hospitalizations every year.
The players
Tekton Research
Tekton Research is a network of clinical research centers that manages the recruitment and testing phases for various medical trials.
The details
The double-blinded study assigns participants to either the vaccine or a placebo group to test the mRNA technology's ability to trigger antibody production. Eligible volunteers must be at least 60 years old, free of immune-suppressing medications, and have not had a norovirus infection within the last 30 days.
Timeline
The clinical trial enrollment is ongoing as of October 2026.
Potential participants are excluded if they had norovirus in the past 30 days.
Market Landscape
This trial utilizes the mRNA vaccine development platform to expand immunization technology beyond respiratory viruses. By leveraging techniques pioneered during the COVID-19 pandemic, researchers are now applying these frameworks to address widespread gastrointestinal pathogens.
Local residents aged 60 and older may qualify for participation, which involves a preliminary eligibility visit and ongoing symptom diary maintenance. The study provides access to experimental mRNA-based immunization, though half of participants will receive a placebo instead.
The takeaway
Interested participants should consult with their primary care physicians to confirm if an investigational study is appropriate given their medical history. Maintaining rigorous hygiene standards remains the primary defense against norovirus until a vaccine is proven effective and widely available.
Further reading
For more information on healthcare recruitment and medical developments, visit Austin Nursing Jobs.
Source note: This article includes information reported by Austin American-Statesman.
Live Poll
Would you participate in a clinical trial to help test a new vaccine?
